Welcome to JEmedis
JEmedis. Our Team. Our Mission.
JEmedis is a driven young business. Small, agile and, above all, innovative.
Our Team
JEmedis has a highly competent, committed team with lean decision-making processes to facilitate quick and easy implementation. In our work, we combine innovative know-how with many years of experience.
Our Mission
In addition to our already established and proven medicine for the treatment of bladder cancer, we are continuing to expand our portfolio to cater to the needs of our patients and customers. Accordingly, JEmedis is currently developing another product towards this end..
In the area of CDMO, our customers benefit from our know-how in innovative product development, which we bring to our customers’ projects and convert into tailor-made processes. That way, we provide you with lasting support in optimising and accelerating manufacturing steps, as well as reducing any risks.
Innovative Active Ingredient Development at JEmedis
At JEmedis, TEAMWORK underlies all of our work. The ability of our employees to work together well as a team is of the utmost importance. In this way, we can transfer the expertise and competence we have built up over many years to projects, products, and new team members. This gives our employees wide-ranging, but also specialised knowledge in many areas, enabling them to see all processes through from start to finish.
Our History
JEmedis is a young business founded in 2021. However, it can draw on decades of experience in the pharmaceutical field, as it was born out of PharmaCept GmbH at its Luckenwalde location. PharmaCept GmbH was established in Berlin in 1998 and specialised in the marketing of pharmaceuticals and medical devices in the area of urology/oncology. In order to further expand our portfolio, we pursued the vision of developing our own drug in this area.
JEmedis GmbH established from PharmaCept GmbH – Luckenwalde location
Development as a CDMO begins
GMP approval obtained and manufacture authorised
Compilation of the team
Construction of our own manufacturing facility at Luckenwalde biotechnology park
First registration of AdriaCept® (as a generic drug to prevent the recurrence of bladder cancer)
For this purpose, a separate manufacturing facility was built in 2015, based in Luckenwalde Biotechnology Park. From then on, the team worked on building the facility into a cGMP manufacturing facility. After 23 successful years of PharmaCept GmbH, parts of the company were sold. JEmedis GmbH was founded at the Luckenwalde location.